Published in Expert Opin Drug Metab Toxicol on May 01, 2010
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'. Semin Immunopathol (2011) 2.78
Functions and therapeutic roles of exosomes in cancer. Front Oncol (2014) 1.18
Transcriptome of extracellular vesicles released by hepatocytes. PLoS One (2013) 0.90
Impact of the Interaction between 3'-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes. Front Genet (2012) 0.84
Liver extracellular vesicles in health and disease. J Extracell Vesicles (2012) 0.83
Considerations for applying metabolomics to the analysis of extracellular vesicles. Front Immunol (2014) 0.80
Biological functions of exosomes in the liver in health and disease. Hepat Mon (2014) 0.78
Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons". Cell Commun Signal (2016) 0.76
Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma. Biomed Res Int (2017) 0.75
Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism. Sci Rep (2017) 0.75
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Shedding microvesicles: artefacts no more. Trends Cell Biol (2009) 8.84
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol (2008) 7.30
Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 6.96
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol (2001) 6.32
Exosomal-like vesicles are present in human blood plasma. Int Immunol (2005) 6.04
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol (2009) 6.03
Structure and chemistry of cytochrome P450. Chem Rev (2005) 5.85
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem (1987) 4.99
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood (2007) 4.73
Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics (2009) 4.27
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem (2003) 4.14
Succinylcholine (succinoylcholine), muscle-relaxant of short action. Lancet (1952) 3.76
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release (2008) 3.62
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother (2005) 3.20
Circulating microparticles: pathophysiology and clinical implications. Blood Rev (2006) 3.07
Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood (2007) 2.92
Glutathione-S-transferase family of enzymes. Mutat Res (2001) 2.74
Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci (2001) 2.54
Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res (2008) 2.41
Cytochromes P450 as versatile biocatalysts. J Biotechnol (2006) 2.36
Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod (2009) 2.17
Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J (2006) 2.13
Proteomic and immunologic analyses of brain tumor exosomes. FASEB J (2008) 2.11
Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol (2005) 1.98
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm (Vienna) (2009) 1.97
"Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol (2001) 1.93
Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol (2001) 1.91
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles. Immunol Res (2006) 1.91
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther (2005) 1.89
Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology (2008) 1.84
The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev (2008) 1.80
Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res (2003) 1.59
TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci (2006) 1.55
Cholinesterase. Its significance in anaesthetic practice. Anaesthesia (1997) 1.55
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene (2006) 1.53
Retracted Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox- and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology (2007) 1.52
Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol (2004) 1.51
The platelet microparticle proteome. J Proteome Res (2005) 1.42
Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J Immunol (2008) 1.37
Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia (2009) 1.37
Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res (2009) 1.34
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol (2003) 1.33
Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2. Biochemistry (2005) 1.31
Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood (1989) 1.27
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics (2006) 1.24
Flavin-containing monooxygenases: mutations, disease and drug response. Trends Pharmacol Sci (2008) 1.24
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab Invest (2007) 1.21
A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res (2006) 1.21
Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both. Traffic (2007) 1.19
Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. Immunology (2008) 1.19
Metabolism of cocaine in man. Clin Pharmacol Ther (1978) 1.19
Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag (2008) 1.17
Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos (2004) 1.15
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun (2008) 1.14
Exosome Display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis (2005) 1.14
Glutathione conjugate mediated toxicities. Toxicol Appl Pharmacol (1990) 1.14
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost (2007) 1.12
Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry (1997) 1.11
Mammalian cytochromes P450--importance of tissue specificity. Biochim Biophys Acta (2006) 1.11
Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol (1996) 1.07
Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J Pharmacol Exp Ther (1980) 1.06
Proteome of endothelial cell-derived procoagulant microparticles. Proteomics (2005) 1.05
Distinct proteome features of plasma microparticles. Proteomics (2005) 1.05
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis (2005) 1.04
Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int Rev Cytol (2007) 1.03
The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research. Brief Funct Genomic Proteomic (2008) 1.01
Acetylation of human serum albumin by p-nitrophenyl acetate. Biochemistry (1975) 0.99
Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb Haemost (2002) 0.98
Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm Res (2004) 0.96
Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp Cell Res (2005) 0.96
Aspirin metabolism and efficacy in postoperative dental pain. Br J Clin Pharmacol (1984) 0.96
Human prostasomes contain chromosomal DNA. Prostate (2009) 0.96
Exosomes secreted by bacterially infected macrophages are proinflammatory. Sci Signal (2008) 0.95
Dynamics of circulating microparticles in liver transplant patients. J Gastrointestin Liver Dis (2008) 0.95
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology (1997) 0.93
The biochemistry of drug metabolism--an introduction: part 3. Reactions of hydrolysis and their enzymes. Chem Biodivers (2007) 0.93
Intracellular transport and localization of microsomal cytochrome P450. Anal Bioanal Chem (2008) 0.93
Dexosomes as a therapeutic cancer vaccine: from bench to bedside. Blood Cells Mol Dis (2005) 0.93
The potential of exosomes in immunotherapy of cancer. Blood Cells Mol Dis (2005) 0.92
Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase. Biochem Biophys Res Commun (2000) 0.90
A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer. Prostate (2009) 0.90
Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex. Drug Metab Pharmacokinet (2007) 0.89
The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes. Chem Biodivers (2007) 0.88
Serum enzymes of drug metabolism. Pharmacol Ther (1987) 0.88
Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol (2004) 0.87
Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide. Mol Pharmacol (1995) 0.83
Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem (2008) 0.83
Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets (2009) 0.82
Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung. Mutagenesis (2008) 0.82
Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases. Clin Chim Acta (1994) 0.81
Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate. J Enzyme Inhib Med Chem (2007) 0.80
Detoxification pathways in the liver. J Inherit Metab Dis (1991) 0.80
The biochemistry of drug metabolism--an introduction: part 1. Principles and overview. Chem Biodivers (2006) 0.79
Hydrolysis of methylprednisolone acetate by human serum cholinesterase. Drug Metab Dispos (1982) 0.78
Extrahepatic drug metabolizing enzymes. J Biochem Mol Toxicol (1999) 0.77
Clinical pharmacology of mivacurium chloride: a review. J Clin Anesth (1992) 0.76
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology (2008) 2.91
Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res (2008) 2.41
Role of S-adenosyl-L-methionine in liver health and injury. Hepatology (2007) 2.21
Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res (2008) 2.14
S-Adenosylmethionine: a control switch that regulates liver function. FASEB J (2002) 2.08
Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J (2002) 2.04
Methionine metabolism and liver disease. Annu Rev Nutr (2008) 1.98
MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest (2012) 1.86
Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology (2012) 1.66
S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci U S A (2006) 1.66
Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology (2010) 1.63
Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol (2005) 1.61
Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology (2007) 1.56
Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol (2008) 1.49
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr (2007) 1.49
S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology (2006) 1.44
GARBAN: genomic analysis and rapid biological annotation of cDNA microarray and proteomic data. Bioinformatics (2003) 1.43
CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology (2009) 1.40
Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis. Alcohol Clin Exp Res (2004) 1.37
Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci U S A (2003) 1.35
Arabidopsis thaliana high-affinity phosphate transporters exhibit multiple levels of posttranslational regulation. Plant Cell (2011) 1.34
Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta. Hepatology (2008) 1.33
Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells. Gastroenterology (2007) 1.30
S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-x(S). Hepatology (2004) 1.30
S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology (2008) 1.30
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res (2010) 1.29
L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine. J Biol Chem (2003) 1.29
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27
Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp Mol Pathol (2008) 1.27
Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1. Biochem J (2005) 1.24
S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology (2002) 1.24
5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology (2004) 1.22
Methylthioadenosine. Int J Biochem Cell Biol (2004) 1.22
Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl (2010) 1.21
Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. Hepatology (2009) 1.20
Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab Invest (2008) 1.19
Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J (2004) 1.19
Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology (2010) 1.19
Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.19
Cloning and characterization of the human glutathione synthetase 5'-flanking region. Biochem J (2005) 1.15
Alcohol, DNA methylation, and cancer. Alcohol Res (2013) 1.14
Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol (2004) 1.14
Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha. Role of NF-kappa B and AP-1. J Biol Chem (2003) 1.14
Inhibition of human betaine-homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine. Biochem J (2007) 1.14
Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology (2010) 1.13
Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes. Hepatology (2009) 1.12
Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation. Hepatology (2009) 1.11
Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology (2007) 1.08
Binding of S-methyl-5'-thioadenosine and S-adenosyl-L-methionine to protein MJ0100 triggers an open-to-closed conformational change in its CBS motif pair. J Mol Biol (2009) 1.07
Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am J Pathol (2010) 1.06
MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology (2013) 1.06
Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol (2004) 1.05
HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology (2010) 1.04
S-Adenosylmethionine and methylthioadenosine inhibit cellular FLICE inhibitory protein expression and induce apoptosis in colon cancer cells. Mol Pharmacol (2009) 1.03
Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology (2010) 1.03
Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. Hepatology (2011) 1.02
Role of AP-1 in the coordinate induction of rat glutamate-cysteine ligase and glutathione synthetase by tert-butylhydroquinone. J Biol Chem (2002) 1.01
Keratin mutation primes mouse liver to oxidative injury. Hepatology (2005) 1.00
Human antigen R contributes to hepatic stellate cell activation and liver fibrosis. Hepatology (2012) 1.00
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide. Hepatology (2010) 0.99
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology (2012) 0.98
Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J Hepatol (2006) 0.97
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J Proteomics (2012) 0.97
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology (2014) 0.96
Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis (2011) 0.95
Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J Cell Physiol (2007) 0.95
Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem (2012) 0.95
S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis. Gastroenterology (2008) 0.95
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology (2013) 0.94
Impaired liver regeneration in mice lacking glycine N-methyltransferase. Hepatology (2009) 0.94
Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis. J Biol Chem (2012) 0.92
S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans (2008) 0.92
The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. Am J Obstet Gynecol (2010) 0.91
SLC30A3 (ZnT3) oligomerization by dityrosine bonds regulates its subcellular localization and metal transport capacity. PLoS One (2009) 0.91
Novel function and intracellular localization of methionine adenosyltransferase 2beta splicing variants. J Biol Chem (2010) 0.91
Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice. Hepatology (2010) 0.91
Transcriptome of extracellular vesicles released by hepatocytes. PLoS One (2013) 0.90
A metabolic signature predicts biological age in mice. Aging Cell (2012) 0.90
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. Hepatology (2010) 0.89
Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? Methods Mol Biol (2010) 0.89
Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R. J Biol Chem (2011) 0.88
Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase. Hepatology (2012) 0.88
15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. J Biol Chem (2004) 0.87
S-adenosylmethionine metabolism and liver disease. Ann Hepatol (2013) 0.86
Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice. Antioxid Redox Signal (2014) 0.86
Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesis. Mol Pharmacol (2008) 0.86
Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology (2010) 0.86